Bioinspired Adaptive Microdrugs Enhance the Chemotherapy of Malignant Glioma: Beyond Their Nanodrugs
Advanced Materials · 2024-08 · 36 (32)
DOI: 10.1002/adma.202405165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 16.06.2024. Verfasst von Xuejiao Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 51…. Hauptthemen laut MEDLINE: Glioma, Antineoplastic Agents, Blood-Brain Barrier. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key R&D Programme of China, Basic and Applied Basic Research Foundation of Guangdong Province, Innovative Research Group Project of the National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Solid nanoparticle‐mediated drug delivery systems are usually confined to nanoscale due to the enhanced permeability and retention effect. However, they remain a great challenge for malignant glioma chemotherapy because of poor drug delivery efficiency and insufficient tumor penetration resulting from the blood–brain barrier/blood–brain tumor barrier (BBB/BBTB). Inspired by biological microparticles (e.g., cells) with excellent adaptive deformation, it is demonstrated that the adaptive microdrugs (even up to 3.0 µm in size) are more efficient than their nanodrugs (less than 200 nm in size) to cross BBB/BBTB and penetrate into tumor tissues, achieving highly efficient chemotherapy of malignant glioma. The distinct delivery of the adaptive microdrugs is mainly attributed to the enhanced interfacial binding and endocytosis via adaptive deformation. As expected, the obtained adaptive microdrugs exhibit enhanced accumulation, deep penetration, and cellular internalization into tumor tissues in comparison with nanodrugs, significantly improving the survival rate of glioblastoma mice. It is believed that the bioinspired adaptive microdrugs enable them to efficiently cross physiological barriers and deeply penetrate tumor tissues for drug delivery, providing an avenue for the treatment of solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, P. R. China.
- South China Advanced Institute for Soft Matter Science and Technology, School of Emergent Soft Matter, South China University of Technology, Guangzhou, 510515, P. R. China.
- Department of Radiotherapy, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan, 511518, P. R. China.
ORCID-Profile: Jun-Bing Fan
Förderung
- National Key R&D Programme of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Innovative Research Group Project of the National Natural Science Foundation of China
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Wang, X., Hao, X., Zhang, Y., Wu, Q., Zhou, J., Cheng, Z., Chen, J., Liu, S., Pan, J., Wang, Y., & Fan, J. B. (2024). Bioinspired Adaptive Microdrugs Enhance the Chemotherapy of Malignant Glioma: Beyond Their Nanodrugs. Advanced Materials, 36(32). https://doi.org/10.1002/adma.202405165
Vancouver
Wang X, Hao X, Zhang Y, Wu Q, Zhou J, Cheng Z, et al. Bioinspired Adaptive Microdrugs Enhance the Chemotherapy of Malignant Glioma: Beyond Their Nanodrugs. Advanced Materials. 2024;36(32). doi:10.1002/adma.202405165
BibTeX
@article{Wang2024,
author = {Wang, Xuejiao and Hao, Xiangrong and Zhang, Yangning and Wu, Qun and Zhou, Jiajia and Cheng, Zhongman and Chen, Jianping and Liu, Sijia and Pan, Jiahao and Wang, Ying and Fan, Jun-Bing},
title = {Bioinspired Adaptive Microdrugs Enhance the Chemotherapy of Malignant Glioma: Beyond Their Nanodrugs},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {32},
doi = {10.1002/adma.202405165}
}
EUVIMED